MedTrace Logo

The Sunlight Exposure Therapy on the Improvement of Depression and Quality of Life in Post-stroke Patients

NCT04036565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2019-08-05

No results posted yet for this study

Summary

Chronic diseases has been the leading causes of death in 2015 to 2017 based on the National database. In particular, cerebrovascular disease was the third in 2015, the fourth in 2016 and 2017. In the Statistical Office of the Ministry of Health and Welfare (2016, 2017,2018). Previous studies have suggested that nearly 30% of the stroke victims present with signs of depression within the first 5 years of illness. Since post-stroke depression significantly affects the patient both physically and psychologically, the emotional disturbances impede the progress and effectiveness of rehabilitation. Regarding the non-pharmacological treatment of melancholia, the phototherapy has been used to treat psychological, behavioral or emotional disorders with satisfactory outcomes.Furthermore, many studies has suggested that artificial light should mimic natural sunlight to reach optimal effect. The benefit of sunlight in human wellbeing has been well documented, therefore we intend to utilize sunlight therapy for stroke patients in order to improve their physical and mental health.

Conditions

Interventions

BEHAVIORAL

sunlight therapy

Exposed to sunlight for at least 30 minutes per day, at least 14 days of exposure duration of 4 weeks.

Sponsors & Collaborators

  • Taipei Veterans General Hospital, Taiwan

    lead OTHER_GOV

Principal Investigators

  • Miao-Yen Chen · School of Nursing, National Taipei University of Nursing and Health Sciences.

Eligibility

Min Age
24 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-09
Primary Completion
2018-04-23
Completion
2018-04-23

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04036565 on ClinicalTrials.gov